{"status": "OK", "response": {"docs": [{"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": "Dr. Neena S. Abraham, a gastroenterologist at the Michael E. DeBakey V.A. Medical Center and associate professor of medicine at the Baylor College of Medicine in Houston, recently took readers' questions about ulcers, a potentially life-threatening condition increasingly tied to Nsaid pain relievers. Here, Dr. Abraham responds to a reader concerned about ulcers and cancer risk.", "headline": {"main": "Can Ulcers Lead to Cancer?", "kicker": "Consults"}, "abstract": "Helicobacter pylori, the bacterium linked to ulcers, plays a role in stomach cancer, though scientists still do not fully understand why some people get gastric cancer and others do not.", "print_page": null, "word_count": 543, "_id": "4fd399118eb7c8105d8d460d", "snippet": "Helicobacter pylori, the bacterium linked to ulcers, plays a role in stomach cancer, though scientists still do not fully understand why some people get gastric cancer and others do not.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://consults.blogs.nytimes.com/2010/01/28/can-stomach-ulcers-lead-to-cancer/", "multimedia": [], "subsection_name": null, "keywords": [{"value": "News", "name": "type_of_material", "rank": "1"}], "byline": {"organization": "THE NEW YORK TIMES", "original": "By THE NEW YORK TIMES", "person": []}, "document_type": "blogpost", "pub_date": "2010-01-28T10:48:27Z", "section_name": "Health"}, {"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": "Proxy materials have been delivered to Biogen Idec by Carl C. Icahn, as the billionaire investor seeks greater control of the biotechnology company's board, a source familiar with the situation told Reuters.", "headline": {"main": "Icahn Said to Seek More Control Over Biogen", "kicker": "DealBook"}, "abstract": "Proxy materials have been delivered to Biogen Idec by Carl Icahn, as the billionaire investor seeks greater control of the biotechnology company's board, a source familiar with the situation told Reuters.", "print_page": null, "word_count": 332, "_id": "4fd399418eb7c8105d8d4ee1", "snippet": "Proxy materials have been delivered to Biogen Idec by Carl Icahn, as the billionaire investor seeks greater control of the biotechnology company's board, a source familiar with the situation told Reuters.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://dealbook.nytimes.com/2010/01/28/icahn-said-to-seek-more-control-over-biogen/", "multimedia": [], "subsection_name": null, "keywords": [{"value": "ClearBridge Advisors", "name": "organizations", "rank": "4"}, {"value": "Biogen Idec Incorporated", "name": "organizations", "rank": "3"}, {"value": "Icahn, Carl C", "name": "persons", "rank": "2"}, {"value": "Biogen Idec Incorporated|BIIB|NASDAQ", "name": "unknown", "rank": "5"}, {"value": "News", "name": "type_of_material", "rank": "1"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1}], "original": "By DEALBOOK"}, "document_type": "blogpost", "pub_date": "2010-01-28T01:42:43Z", "section_name": "Business Day"}], "meta": {"hits": 2, "offset": 0, "time": 53}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}